BIOSYMETRICS, INC.
AI-based zebrafish behavioral screening platform for identifying Alcohol Use Disorder therapeutics, combined with novel chemical series discovery
- Sector
- Biotech
- Headquarters
- HUNTINGTON, NY
- Founded
- 2016
- Latest Form D
- $4.9M, Aug 2021
- Total capital
- $5.3M
- Federal grants
- $423K
- 1 award · 2025
- Rank in peer group#29 of 48
- Private capital raised
- $4.9M
- 1 Form D · last Aug 2021
- 63 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 3
- 5 pending · first 2022
- Rank in peer group#5 of 48
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · AI-driven in vivo profiling in zebrafish: a platform for alcohol use disorder therapeutic discovery$423K
- Private capital raisedForm D · SEC · 1st filing$4.9M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 48 peers
Line = medianBiotech · Platform
- Federal grantsBelow median
- Granted patents#5 · top 10%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Gabriel MussoResearcherDirectorLinked by 2 patents
- Anthony IacovoneExecutive Officer, DirectorNamed in SEC Form D filings
- Scott RussoDirectorNamed in SEC Form D filings
What it has protected
USPTO · 3 granted of 8- GrantedMethods, Systems, And Frameworks For Debiasing Data In Drug Discovery PredictionsUSPTOUS 12,555,041
- GrantedMethods, Systems, And Frameworks For Debiasing Data In Drug Discovery PredictionsUSPTOUS 12,369,861
- PendingMethods, Systems, And Frameworks For Gene Disease Prioritization In Drug DiscoveryUSPTOApplication 18058945
Show all 8 patent records
- Methods, Systems, And Frameworks For Debiasing Data In Drug Discovery PredictionsFeb 17, 2026 · US 12,555,041Granted
- Methods, Systems, And Frameworks For Debiasing Data In Drug Discovery PredictionsJul 29, 2025 · US 12,369,861Granted
- Methods, Systems, And Frameworks For Gene Disease Prioritization In Drug DiscoveryJun 5, 2025 · Application 18058945Pending
- Data Processing Pipeline And Platform For Zebrafish PhenotypingMay 16, 2024 · Application 18150168Pending
- Methods, Systems, And Frameworks For Federated Learning While Ensuring Bi Directional Data SecurityJan 18, 2024 · Application 18058754Pending
- Methods, Systems, And Frameworks For Data Analytics Using Machine LearningSep 15, 2022 · Application 17831571Pending
- Methods, Systems, And Frameworks For Data Analytics Using Machine LearningJul 5, 2022 · US 11,379,757Granted
- Methods, Systems, And Frameworks For Data Analytics Using Machine LearningApplication 63383749Pending
Related companies, and why
- Quralis CorporationSimilar federal contract value in Biotech · null in contracts
- Scribe Therapeutics Inc.Similar federal contract value in Biotech · null in contracts
- GENEVENTIV THERAPEUTICS, INC.Similar federal contract value in Biotech · null in contracts
- CYTEGEN CORPSimilar federal contract value in Biotech · null in contracts
- BYOMASS, INC.Similar federal contract value in Biotech · null in contracts
- G1 THERAPEUTICS, INC.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .